We are live on ! Find out more
RC

Rangeley Capital Portfolio holdings

AUM $103M
1-Year Est. Return 77.32%
This Fund
S&P 500
This Quarter Est. Return
+20.64%
1 Year Est. Return
+77.32%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$83.8M
AUM Growth
-$9.56M
Cap. Flow
-$15.6M
Cap. Flow %
-18.56%
Top 10 Hldgs %
54.2%
Holding
117
New
40
Increased
13
Reduced
18
Closed
44

Top Buys

Rank Stock Value
1
PRTA icon
Prothena Corp
PRTA
+$5.37M
2
SAGE
Sage Therapeutics
SAGE
+$2.54M
3
ITOS
iTeos Therapeutics
ITOS
+$2.43M
4
SKX
Skechers
SKX
+$2.07M
5
SGRY icon
Surgery Partners
SGRY
+$1.67M

Top Sells

Rank Stock Value
1
BUR icon
Burford Capital
BUR
+$3.92M
2
CLMT icon
Calumet Specialty Products
CLMT
+$2.55M
3
AMPY icon
Amplify Energy
AMPY
+$2.5M
4
LQDA icon
Liquidia Corp
LQDA
+$2.36M
5
PARR icon
Par Pacific Holdings
PARR
+$2.02M

Sector Composition

Rank Sector Weight
1 Healthcare 46.94%
2 Energy 12.53%
3 Real Estate 8.38%
4 Consumer Discretionary 7.77%
5 Materials 7.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SAGE
1
DELISTED
Sage Therapeutics
SAGE
$6.66M 7.94%
730,000
+345,313
+90% +$2.54M
DK icon
2
Delek US
DK
$3.95B
$6.63M 7.91%
313,000
-26,000
-8% -$437K
ARVN icon
3
Arvinas
ARVN
$530M
$5.11M 6.1%
694,800
+151,800
+28% +$1.12M
CLMT icon
4
Calumet Specialty Products
CLMT
$3.6B
$5.03M 6%
319,000
-200,787
-39% -$2.55M
PRTA icon
5
Prothena Corp
PRTA
$455M
$4.34M 5.18%
+715,367
New +$5.37M
KROS icon
6
Keros Therapeutics
KROS
$202M
$3.81M 4.55%
285,400
-122,834
-30% -$1.66M
SGRY icon
7
Surgery Partners
SGRY
$1.98B
$3.69M 4.4%
166,060
+75,160
+83% +$1.67M
CHTR icon
8
CALL
Charter Communications
CHTR
$15.7B
$3.68M 4.39%
9,000
– –
WOW
9
DELISTED
WideOpenWest
WOW
$3.24M 3.87%
799,000
+41,752
+6% +$179K
FLL icon
10
Full House Resorts
FLL
$84.5M
$3.23M 3.85%
882,426
-6,678
-0.8% -$22.4K
ITOS
11
DELISTED
iTeos Therapeutics
ITOS
$3.01M 3.59%
+302,080
New +$2.43M
SEG
12
Seaport Entertainment Group
SEG
$336M
$2.95M 3.52%
158,000
-6,500
-4% -$125K
ABUS icon
13
Arbutus Biopharma
ABUS
$871M
$2.67M 3.19%
865,000
-484,000
-36% -$1.61M
CORZW icon
14
Core Scientific Inc Tranche 1 Warrants
CORZW
$1.39B
$2.5M 2.98%
+146,200
New +$727K
NLOP
15
Net Lease Office Properties
NLOP
$171M
$2.28M 2.72%
70,000
-40,064
-36% -$1.23M
SKX
16
DELISTED
Skechers
SKX
$2.27M 2.71%
+36,000
New +$2.07M
THRD
17
DELISTED
Third Harmonic Bio
THRD
$1.57M 1.88%
290,000
+20,000
+7% +$99.7K
CDZI icon
18
Cadiz
CDZI
$259M
$1.4M 1.67%
469,000
-161,000
-26% -$462K
STHO icon
19
Star Holdings Shares of Beneficial Interest
STHO
$112M
$1.34M 1.6%
172,000
+43,000
+33% +$297K
UAN icon
20
CVR Partners
UAN
$1.27B
$1.33M 1.59%
15,000
-8,183
-35% -$658K
GEL icon
21
Genesis Energy
GEL
$1.81B
$1.28M 1.52%
74,000
-115,000
-61% -$1.74M
WBA
22
DELISTED
Walgreens Boots Alliance
WBA
$1.17M 1.4%
+102,000
New +$1.14M
NRP icon
23
Natural Resource Partners
NRP
$1.3B
$1.16M 1.38%
+12,100
New +$1.18M
AMPY icon
24
Amplify Energy
AMPY
$155M
$896K 1.07%
280,000
-840,000
-75% -$2.5M
BUR icon
25
Burford Capital
BUR
$922M
$727K 0.87%
51,000
-300,000
-85% -$3.92M
1
2 3 4 5

Similar funds

EFT
Envision Financial Transparency Greensboro, North Carolina $103M AUM
GWL
Generations Wealth LLC Mason, Ohio $103M AUM
CC
Caspian Capital New York $103M AUM
ABLA
Alan B. Lancz & Associates Toledo, Ohio $103M AUM 31.99% 1-Year Est. Return
SPCM
Stoic Point Capital Management Palo Alto, California $103M AUM
OPAM
Olympus Peak Asset Management Greenwich, Connecticut $103M AUM 58.06% 1-Year Est. Return
ES
ETF Store Overland Park, Kansas $103M AUM 15.78% 1-Year Est. Return
IMT
Investment Management Trust Fitchburg, Massachusetts $103M AUM

Rangeley Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Rangeley Capital held 117 positions worth $83.8M, down 10% from $93.4M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Rangeley Capital withdrew a net $15.6M in Q2 2025, closing 44 positions and reducing 18 holdings. Its most notable exit was Liquidia Corp, an estimated $2.36M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 29% a quarter earlier, followed by Energy and Real Estate.

Against the trend, Rangeley Capital opened a new position in Prothena Corp worth $4.34M.

  • Rangeley Capital's largest Q2 2025 buy was Prothena Corp: 715,367 shares worth $4.34M.
  • Rangeley Capital added most to Sage Therapeutics in Q2 2025, an estimated $2.54M increase.
  • Rangeley Capital's biggest Q2 2025 reduction was Burford Capital, cutting an estimated $3.92M.
  • Rangeley Capital fully exited Liquidia Corp in Q2 2025, selling an estimated $2.36M.
  • Rangeley Capital's ten largest holdings make up 54% of its $83.8M portfolio in Q2 2025.
  • Rangeley Capital opened 40 new positions and closed 44 in Q2 2025.
  • Rangeley Capital's portfolio value fell 10% quarter-over-quarter to $83.8M.

Based on Rangeley Capital's 13F filing for Q2 2025, filed 14 Aug 2025.